Paloma Partners’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,726
Closed -$373K 1831
2021
Q4
$373K Buy
+16,726
New +$436K 0.01% 1283
2021
Q3
Sell
-11,764
Closed -$458K 1195
2021
Q2
$458K Buy
11,764
+208
+2% +$7.46K 0.01% 1056
2021
Q1
$333K Buy
+11,556
New +$395K 0.01% 1406
2020
Q1
Sell
-36,249
Closed -$1.36M 1361
2019
Q4
$1.36M Buy
+36,249
New +$1.63M 0.02% 794
2019
Q3
Sell
-18,900
Closed -$988K 1997
2019
Q2
$988K Sell
18,900
-57
-0.3% -$3.34K 0.02% 693
2019
Q1
$1.31M Buy
+18,957
New +$1.27M 0.03% 609
2018
Q1
Sell
-52,400
Closed -$5.74M 1983
2017
Q4
$5.74M Buy
52,400
+50,271
+2,361% +$5.02M 0.08% 242
2017
Q3
$210K Sell
2,129
-7,891
-79% -$765K ﹤0.01% 1968
2017
Q2
$1.01M Buy
10,020
+718
+8% +$77.4K 0.01% 1186
2017
Q1
$1.07M Buy
+9,302
New +$1.08M 0.01% 1198
2016
Q4
Sell
-1,825
Closed -$205K 1990
2016
Q3
$205K Buy
+1,825
New +$210K ﹤0.01% 1738
2016
Q2
Sell
-3,875
Closed -$436K 2166
2016
Q1
$436K Buy
3,875
+1,672
+76% +$174K 0.01% 1372
2015
Q4
$240K Buy
+2,203
New +$252K 0.01% 1463
2015
Q3
Sell
-17,568
Closed -$2M 1640
2015
Q2
$2M Buy
17,568
+12,268
+231% +$1.49M 0.04% 441
2015
Q1
$554K Buy
+5,300
New +$565K 0.02% 735
2014
Q1
Sell
-3,621
Closed -$691K 723
2013
Q4
$691K Buy
+3,621
New +$674K 0.03% 500

Other funds holding CLB

Paloma Partners's CLB Position: Q1 2022 in Review

Paloma Partners sold out of Core Laboratories (CLB) in Q1 2022, closing a stake of 16,726 shares — an estimated $373K sold.

Paloma Partners first reported a position in CLB in Q4 2013 and held it in 16 quarters. The position peaked at $5.74M in Q4 2017. 196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.

  • Paloma Partners reported no remaining Core Laboratories position as of Q1 2022 after selling out during the quarter.
  • Paloma Partners sold 16,726 Core Laboratories shares in Q1 2022, an estimated $373K.
  • Paloma Partners first reported a position in Core Laboratories in Q4 2013 and held it in 16 quarters.
  • Paloma Partners's Core Laboratories position peaked at $5.74M in Q4 2017.
  • 196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.

Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.